Everest Medicines Ltd. (HK:1952) has released an update.
Everest Medicines Limited has scheduled a board meeting for August 27, 2024, to review and approve the company’s interim results for the first half of the year. The announcement emphasizes the importance of this meeting for the company’s stakeholders and investors, underscoring a potential impact on the company’s financial performance.
For further insights into HK:1952 stock, check out TipRanks’ Stock Analysis page.
